
Texas Instruments Incorporated
- What it sells
- Analog is 79% of revenue (fiscal year to Dec 2025), up from 74% two years earlier.
- Growing?
- Yes: revenue up 28% on a year earlier (quarter ended Sep 2026); earnings per share up 41% over the last four quarters.
- Expensive?
- Pricier than usual: 40.5× trailing earnings; its five-year median is 28.2×. Priced 93% above the peer median of 21x.
- Analysts?
- 57% of 35 say buy; average 12-month target $337, 8% above today's price.
- Risky?
- Swingier than most large companies: its price swung 44% over the past year (the S&P 500's 14%), and it fell as much as 34% since Nov 2021.
Texas Instruments Incorporated (TI) designs and manufactures analog semiconductors and embedded processors, selling standard catalog parts through direct sales and broad distribution; revenue is primarily from unit shipments of ICs across industrial and automotive end markets.
More about Texas Instruments
Market Position
TI is a leading global supplier in analog with a scaled 300mm analog manufacturing footprint and a large, long-life product catalog that supports high service levels and longevity programs for industrial customers.
Key Segments
TI reports two operating segments: Analog and Embedded Processing (with Other items including certain legacy and corporate activities).
How has the stock done?
Over the past month TXN rose 10.9%; the semiconductor ETF (SMH) fell 15.1% and the S&P 500 fell 2.7%.
Over the past six months TXN rose 5.9%; the semiconductor ETF (SMH) fell 10.6% and the S&P 500 rose 2.6%.
Over the past year TXN rose 91.6%; the semiconductor ETF (SMH) rose 41.1% and the S&P 500 rose 10.8%.
Over five years TXN rose 64.4%; the semiconductor ETF (SMH) rose 233.3% and the S&P 500 rose 62.0%.
From Nov 8, 2024 to Apr 21, 2025, the deepest drop from a high since Nov 2021
How much the price swings in a year; the S&P 500's was 14%
When the S&P 500 moves 1%, the stock has moved about 1.6% the same way
Show the earnings releases
| Released | Quarter | Revenue | EPS vs estimate | Stock, day after | 5 days after |
|---|---|---|---|---|---|
| Oct 21, 2026 | ended Sep 2026 | $6.1B (+28% vs a year earlier) | $2.62 vs $2.43 (beat) | +0.6% | +11.5% |
| Jul 22, 2026 | ended Jun 2026 | $5.5B (+23% vs a year earlier) | $2.14 vs $1.94 (beat) | −2.2% | −6.9% |
| Apr 22, 2026 | ended Mar 2026 | $4.8B (+19% vs a year earlier) | $1.68 vs $1.37 (beat) | +21.1% | +15.5% |
| Jan 27, 2026 | ended Dec 2025 | $4.4B (+10% vs a year earlier) | $1.27 vs $1.31 (missed) | +10.0% | +14.6% |
| Oct 21, 2025 | ended Sep 2025 | $4.7B (+14% vs a year earlier) | — | −4.9% | −7.1% |
| Jul 22, 2025 | ended Jun 2025 | $4.4B (+16% vs a year earlier) | — | −13.2% | −10.8% |
| Apr 23, 2025 | ended Mar 2025 | $4.1B (+11% vs a year earlier) | — | +10.5% | +9.1% |
| Jan 23, 2025 | ended Dec 2024 | $4.0B (−2% vs a year earlier) | — | −5.9% | −6.0% |
| Oct 22, 2024 | ended Sep 2024 | $4.2B (−8% vs a year earlier) | — | +3.0% | +8.0% |
| Jul 23, 2024 | ended Jun 2024 | $3.8B (−16% vs a year earlier) | — | −3.7% | −2.4% |
| Apr 23, 2024 | ended Mar 2024 | $3.7B (−16% vs a year earlier) | — | +7.0% | +7.9% |
| Jan 23, 2024 | ended Dec 2023 | $4.1B (−13% vs a year earlier) | — | −2.7% | −7.3% |
| Oct 24, 2023 | ended Sep 2023 | $4.5B (−14% vs a year earlier) | — | −3.1% | −2.9% |
| Jul 25, 2023 | ended Jun 2023 | $4.5B (−13% vs a year earlier) | — | −4.3% | −3.0% |
| Apr 25, 2023 | ended Mar 2023 | $4.4B (−11% vs a year earlier) | — | −6.5% | −6.8% |
| Jan 24, 2023 | ended Dec 2022 | $4.7B (−3% vs a year earlier) | — | −1.8% | −0.5% |
| Oct 25, 2022 | ended Sep 2022 | $5.2B (+13% vs a year earlier) | — | −2.3% | +0.8% |
| Jul 26, 2022 | ended Jun 2022 | $5.2B (+14% vs a year earlier) | — | +5.1% | +8.6% |
| Apr 26, 2022 | ended Mar 2022 | $4.9B (+14% vs a year earlier) | — | −2.6% | −0.8% |
| Jan 25, 2022 | ended Dec 2021 | $4.8B (+19% vs a year earlier) | — | 0.0% | +1.7% |
Change in closing price from the first day shown, or with Price the closing price itself. Prices: Yahoo Finance, to Nov 12, 2026. Dashed lines: the days the company released earnings (its SEC 8-K filings); EPS estimates: Yahoo Finance. The stock's move after a release runs from the last close before its day to the close the day after (or five days after), so a release before the open counts like one after the close.
Is the business growing?
Revenue was $6.1B in the quarter ended Sep 2026, up 28% from a year earlier.
Show the data
| Quarter ended | Revenue | vs a year earlier |
|---|---|---|
| Dec 2022 | $4.7B | −3% |
| Mar 2023 | $4.4B | −11% |
| Jun 2023 | $4.5B | −13% |
| Sep 2023 | $4.5B | −14% |
| Dec 2023 | $4.1B | −13% |
| Mar 2024 | $3.7B | −16% |
| Jun 2024 | $3.8B | −16% |
| Sep 2024 | $4.2B | −8% |
| Dec 2024 | $4.0B | −2% |
| Mar 2025 | $4.1B | +11% |
| Jun 2025 | $4.4B | +16% |
| Sep 2025 | $4.7B | +14% |
| Dec 2025 | $4.4B | +10% |
| Mar 2026 | $4.8B | +19% |
| Jun 2026 | $5.5B | +23% |
| Sep 2026 | $6.1B | +28% |
Revenue went from $20.0B in FY22 to $17.7B in FY25; net income from $8.7B to $5.0B.
Show the data
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY22 | $20.0B | $8.7B |
| FY23 | $17.5B | $6.5B |
| FY24 | $15.6B | $4.8B |
| FY25 | $17.7B | $5.0B |
In the fiscal year to Dec 2025, Analog was 79% and Embedded Processing was 15% of revenue; Analog rose from 74% in the fiscal year to Dec 2023.
Show the data
| Fiscal year | Part | Revenue | Share |
|---|---|---|---|
| FY2023 | Analog | $13.0B | 74% |
| FY2023 | Embedded Processing | $3.4B | 19% |
| FY2023 | Other | $1.1B | 6% |
| FY2024 | Analog | $12.2B | 78% |
| FY2024 | Embedded Processing | $2.5B | 16% |
| FY2024 | Other | $947M | 6% |
| FY2025 | Analog | $14.0B | 79% |
| FY2025 | Embedded Processing | $2.7B | 15% |
| FY2025 | Other | $979M | 6% |
A year earlier $1.48
Diluted, from SEC filings
The P/E of 40.5× over the 41% EPS growth of the last four quarters; near 1 or below is cheap for the growth
Quarters: Texas Instruments Incorporated's SEC filings, named by the month they end. Fiscal years: Texas Instruments Incorporated's annual reports to the SEC.
How it makes money
Of every $100 in revenue, $28.3 ends up as net income. Net margin fell from 43.7% to 28.3% over the past 3 years.
Show the data
| Quarter ended | Gross | Operating | Net |
|---|---|---|---|
| Dec 2022 | 66.1% | 46.6% | 42.0% |
| Mar 2023 | 65.4% | 44.2% | 39.0% |
| Jun 2023 | 64.2% | 43.5% | 38.0% |
| Sep 2023 | 62.1% | 41.7% | 37.7% |
| Dec 2023 | 59.6% | 37.6% | 33.6% |
| Mar 2024 | 57.2% | 35.1% | 30.2% |
| Jun 2024 | 57.8% | 32.7% | 29.5% |
| Sep 2024 | 59.6% | 37.4% | 32.8% |
| Dec 2024 | 57.7% | 34.4% | 30.1% |
| Mar 2025 | 56.8% | 32.5% | 29.0% |
| Jun 2025 | 57.9% | 35.1% | 29.1% |
| Sep 2025 | 57.4% | 35.1% | 28.8% |
| Dec 2025 | 55.9% | 33.3% | 26.3% |
| Mar 2026 | 58.0% | 37.5% | 32.0% |
| Jun 2026 | 61.4% | 42.3% | 36.2% |
| Sep 2026 | 64.2% | 47.5% | 40.0% |
−11.7 pts over 3 years
−16.6 pts over 3 years
−15.4 pts over 3 years
Each margin is that line of the income statement divided by revenue. Fiscal year: Texas Instruments Incorporated's annual reports to the SEC; quarters: SEC filings.
Where it is in the chip cycle
Gross margin 64.2% and rising for 3 quarters; inventory at 231 days, down from 252 a year earlier; capital spending 12.4% of revenue over the last 4 quarters.
Show the data
| Period | Inventory days |
|---|---|
| FY22 | 161 |
| FY23 | 225 |
| FY24 | 252 |
| FY25 | 231 |
How many days of sales are sitting in stock. Rising inventory days often come before a downturn: chips are being made faster than they sell.
Show the data
| Period | Capital spending |
|---|---|
| Sep ’25 | 25.2% |
| Dec ’25 | 20.9% |
| Mar ’26 | 14.0% |
| Jun ’26 | 9.4% |
| Sep ’26 | 7.6% |
Money put into factories and equipment. Heavy spending late in an upswing can leave the industry with too much capacity when demand cools.
Gross margin by fiscal quarter, from SEC filings. Inventory days: year-end inventory over that year's cost of revenue, times 365.
Customers and suppliers
Texas Instruments's latest annual report names none of its suppliers or customers, but one customer it does not name accounts for 12% of its revenue.
Their suppliers
Suppliers
Customers
Texas Instruments's 10-K for the year to Dec 2025 gives one customer's share of its revenue: Customer Number One (12%).
Show the filings' numbers
| Period | Customer | Share of revenue | Filing |
|---|---|---|---|
| Year ended Dec 2024 | Customer Number One | 12% | 10-K filed Feb 6, 2026 |
| Year ended Dec 2025 | Customer Number One | 12% | 10-K filed Feb 6, 2026 |
From Texas Instruments Incorporated's 10-Q and 10-K filings (XBRL): each customer whose share of revenue a filing tags, under the filing's own label, so “Customer A” in one filing can be another company in the next; a later filing's figures for a period replace an earlier one's.
Show the filing's words
| Company | Role | In the filing's words |
|---|---|---|
| One of our end customers (unnamed) | customer | “One of our end customers accounted for 12% of revenue in both 2025 and 2024, recognized primarily in our Analog segment.” |
| UMC (20-F filed Apr 30, 2026) | calls it a customer | “Our primary customers, in terms of our sales revenues, include premier integrated device manufacturers, such as Texas Instruments and Intel, plus leading fabless design companies, such as MediaTek, Realtek and Novatek.” |
Only the companies Texas Instruments names in its 10-K filed Feb 6, 2026 (SEC). The supply chain joins the latest annual reports of the companies on it and the 8-Ks they filed since: a link shows when either side's report names the other, so it grows as more reports are read. Hover a name for the filing's own words. Customers it does not name are listed as the filing describes them.
Is it expensive?
P/E of 40.5x, above the peer median of 21x, so it needs earnings to keep growing to hold up.
Priced 93% above the peer median of 21x.
Show the data
| Company | P/E (trailing) |
|---|---|
| AMD · Advanced Micro Devices, Inc. | 127× |
| AVGO · Broadcom Inc. | 46.5× |
| TXN · Texas Instruments Incorporated | 40.5× |
| NVDA · NVIDIA Corporation | 21× |
| MU · Micron Technology, Inc. | 10.8× |
| SKHY · SK hynix Inc. | 8.8× |
At 40.5× trailing earnings TXN is above most of its five-year range; the five-year median is 28.2×.
Show the data
| Date | Trailing P/E |
|---|---|
| Nov 8, 2021 | 24.7× |
| Feb 8, 2022 | 20.9× |
| May 10, 2022 | 19.2× |
| Aug 10, 2022 | 20.0× |
| Nov 8, 2022 | 17.6× |
| Feb 9, 2023 | 18.6× |
| May 11, 2023 | 18.1× |
| Aug 11, 2023 | 20.0× |
| Nov 9, 2023 | 18.6× |
| Feb 12, 2024 | 22.8× |
| May 13, 2024 | 29.3× |
| Aug 13, 2024 | 34.2× |
| Nov 11, 2024 | 40.1× |
| Feb 13, 2025 | 34.8× |
| May 15, 2025 | 35.6× |
| Aug 15, 2025 | 35.6× |
| Nov 13, 2025 | 29.6× |
| Feb 17, 2026 | 41.5× |
| May 18, 2026 | 51.5× |
| Aug 18, 2026 | 41.4× |
| Nov 12, 2026 | 40.5× |
Closing price over diluted earnings per share of the last four reported quarters, as known on each day (a quarter counts 35 days after it ends). From SEC filings; earnings per share adjusted for splits.
What analysts expect
The average analyst price target is $337, 8% above the current price; 57% of 35 analysts rate it a buy; earnings beat estimates in 3 of the last 4 quarters.
Buy or Strong Buy: 20 analysts (57%). Sell or Strong Sell: 2.
Over the past year the average of the analysts' latest price targets went from $200.37 to $332.52 (+66%), while TXN went from $162.23 to $312.48 (+93%). In the past three months targets were raised 7 times and cut 4 times. 7 upgrades and 1 downgrade over the year; the latest: Freedom Broker moved it to Buy from Hold on Oct 22, 2026.
Show every change
| Date | Firm | Change | Rating | Target |
|---|---|---|---|---|
| Oct 22, 2026 | Jefferies | Target raised | Hold | $300.00, was $260.00 |
| Oct 22, 2026 | Freedom Broker | Upgrade | Buy, was Hold | $330.00, was $260.00 |
| Oct 22, 2026 | UBS | Target cut | Buy | $360.00, was $380.00 |
| Oct 22, 2026 | Morgan Stanley | Target raised | Underweight | $278.00, was $255.00 |
| Oct 22, 2026 | Barclays | Target raised | Equal-Weight | $280.00, was $250.00 |
| Oct 22, 2026 | JP Morgan | Target raised | Overweight | $365.00, was $340.00 |
| Oct 22, 2026 | Stifel | Target raised | Buy | $370.00, was $360.00 |
| Oct 22, 2026 | Rosenblatt | Target raised | Buy | $360.00, was $350.00 |
| Oct 22, 2026 | Mizuho | Target cut | Neutral | $290.00, was $305.00 |
| Oct 20, 2026 | Wells Fargo | Target cut | Equal-Weight | $300.00, was $310.00 |
| Oct 19, 2026 | TD Cowen | Target cut | Buy | $330.00, was $340.00 |
| Aug 17, 2026 | Cantor Fitzgerald | Target kept | Neutral | $340.00 |
| Jul 24, 2026 | Rosenblatt | Target raised | Buy | $350.00, was $330.00 |
| Jul 23, 2026 | Bernstein | Target raised | Market Perform | $290.00, was $250.00 |
| Jul 23, 2026 | JP Morgan | Target raised | Overweight | $340.00, was $280.00 |
| Jul 23, 2026 | Morgan Stanley | Target raised | Underweight | $255.00, was $230.00 |
| Jul 23, 2026 | TD Cowen | Target cut | Buy | $340.00, was $360.00 |
| Jul 23, 2026 | Truist Securities | Target raised | Hold | $300.00, was $278.00 |
| Jul 23, 2026 | Mizuho | Target raised | Neutral | $305.00, was $300.00 |
| Jul 23, 2026 | Baird | Target raised | Outperform | $385.00, was $300.00 |
| Jul 23, 2026 | Goldman Sachs | Target raised | Sell | $225.00, was $200.00 |
| Jul 23, 2026 | Benchmark | Target raised | Buy | $360.00, was $315.00 |
| Jul 23, 2026 | Wells Fargo | Target raised | Equal-Weight | $310.00, was $300.00 |
| Jul 23, 2026 | Evercore ISI Group | Target raised | Outperform | $330.00, was $316.00 |
| Jul 23, 2026 | Keybanc | Target raised | Overweight | $400.00, was $390.00 |
| Jul 21, 2026 | Susquehanna | Target raised | Positive | $340.00, was $300.00 |
| Jul 20, 2026 | Morgan Stanley | Target raised | Underweight | $230.00, was $221.00 |
| Jul 14, 2026 | Keybanc | Target raised | Overweight | $390.00, was $325.00 |
| Jul 13, 2026 | TD Cowen | Target raised | Buy | $360.00, was $300.00 |
| Jun 29, 2026 | UBS | Target raised | Buy | $350.00, was $295.00 |
| Jun 29, 2026 | Cantor Fitzgerald | Target raised | Neutral | $340.00, was $300.00 |
| Jun 24, 2026 | Stifel | Target raised | Buy | $360.00, was $340.00 |
| Jun 15, 2026 | Citigroup | Target raised | Buy | $345.00, was $280.00 |
| Jun 9, 2026 | Wells Fargo | Target raised | Equal-Weight | $300.00, was $260.00 |
| May 26, 2026 | B of A Securities | Target raised | Buy | $370.00, was $320.00 |
| May 22, 2026 | Seaport Global | Upgrade | Buy, was Neutral | $400.00 |
| May 19, 2026 | Mizuho | Target raised | Neutral | $300.00, was $255.00 |
| May 13, 2026 | Cantor Fitzgerald | Target raised | Neutral | $300.00, was $280.00 |
| Apr 23, 2026 | UBS | Target raised | Buy | $295.00, was $260.00 |
| Apr 23, 2026 | Citigroup | Target raised | Buy | $280.00, was $235.00 |
| Apr 23, 2026 | JP Morgan | Target raised | Overweight | $280.00, was $227.00 |
| Apr 23, 2026 | Jefferies | Target raised | Hold | $260.00, was $210.00 |
| Apr 23, 2026 | Truist Securities | Target raised | Hold | $278.00, was $225.00 |
| Apr 23, 2026 | TD Cowen | Target raised | Buy | $300.00, was $250.00 |
| Apr 23, 2026 | Cantor Fitzgerald | Target raised | Neutral | $280.00, was $250.00 |
| Apr 23, 2026 | Stifel | Target raised | Buy | $290.00, was $250.00 |
| Apr 23, 2026 | Evercore ISI Group | Target raised | Outperform | $316.00, was $270.00 |
| Apr 23, 2026 | Wells Fargo | Target raised | Equal-Weight | $260.00, was $215.00 |
| Apr 23, 2026 | Keybanc | Target raised | Overweight | $325.00, was $240.00 |
| Apr 23, 2026 | Benchmark | Target raised | Buy | $315.00, was $250.00 |
| Apr 23, 2026 | Barclays | Upgrade | Equal-Weight, was Underweight | $250.00, was $175.00 |
| Apr 23, 2026 | Rosenblatt | Target raised | Buy | $330.00, was $240.00 |
| Apr 23, 2026 | Baird | Target raised | Outperform | $300.00, was $225.00 |
| Apr 23, 2026 | Goldman Sachs | Target raised | Sell | $200.00, was $175.00 |
| Apr 23, 2026 | B of A Securities | Upgrade | Buy, was Neutral | $320.00, was $235.00 |
| Apr 17, 2026 | Mizuho | Upgrade | Neutral, was Underperform | $215.00, was $160.00 |
| Apr 9, 2026 | Stifel | Upgrade | Buy, was Hold | $250.00, was $215.00 |
| Feb 23, 2026 | Cantor Fitzgerald | Target raised | Neutral | $250.00, was $225.00 |
| Feb 5, 2026 | Rosenblatt | Target kept | Buy | $240.00 |
| Jan 28, 2026 | Jefferies | Target raised | Hold | $210.00, was $180.00 |
| Jan 28, 2026 | JP Morgan | Target raised | Overweight | $227.00, was $210.00 |
| Jan 28, 2026 | Goldman Sachs | Target raised | Sell | $175.00, was $156.00 |
| Jan 28, 2026 | UBS | Target raised | Buy | $260.00, was $245.00 |
| Jan 28, 2026 | Wells Fargo | Target raised | Equal-Weight | $215.00, was $185.00 |
| Jan 28, 2026 | Cantor Fitzgerald | Target raised | Neutral | $225.00, was $190.00 |
| Jan 28, 2026 | Keybanc | Target raised | Overweight | $240.00, was $220.00 |
| Jan 28, 2026 | Stifel | Target raised | Hold | $215.00, was $200.00 |
| Jan 28, 2026 | B of A Securities | Upgrade | Neutral, was Underperform | $235.00, was $185.00 |
| Jan 28, 2026 | Mizuho | Target raised | Underperform | $160.00, was $145.00 |
| Jan 28, 2026 | Deutsche Bank | Target raised | Hold | $205.00, was $185.00 |
| Jan 28, 2026 | Truist Securities | Target raised | Hold | $225.00, was $195.00 |
| Jan 28, 2026 | Benchmark | Target raised | Buy | $250.00, was $220.00 |
| Jan 28, 2026 | Rosenblatt | Target raised | Buy | $240.00, was $200.00 |
| Jan 22, 2026 | Susquehanna | Target raised | Positive | $225.00, was $200.00 |
| Jan 16, 2026 | Stifel | Target raised | Hold | $200.00, was $170.00 |
| Jan 15, 2026 | Wells Fargo | Target raised | Equal-Weight | $185.00, was $170.00 |
| Dec 19, 2025 | Truist Securities | Target raised | Hold | $195.00, was $175.00 |
| Dec 15, 2025 | Goldman Sachs | Downgrade | Sell, was Buy | $156.00, was $200.00 |
Show the data
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec ’25 | $1.31 | $1.27 | −3.1% |
| Mar ’26 | $1.37 | $1.68 | +22.6% |
| Jun ’26 | $1.94 | $2.14 | +10.3% |
| Sep ’26 | $2.43 | $2.62 | +7.8% |
The day after each of these reports the stock moved +10.0% (Dec 2025, missed); +21.1% (Mar 2026, beat); −2.2% (Jun 2026, beat); +0.6% (Sep 2026, beat).
For the quarter ending Dec 2026 (Texas Instruments reports on Jan 26, 2027), analysts expect revenue of $6.1B, up 37% on a year earlier. For the fiscal year ending Dec 2027, they expect adjusted earnings of $11.58 a share, 28% more than the year before's estimate of $9.06, and revenue of $26.3B, up 17% on the year before's estimate.
Dec 2025: $4.4B; range $6.0B to $6.2B; 23 analysts
Adjusted. The year to Dec 2026: $9.06 expected; range $9.79 to $13.50; 27 analysts
The year to Dec 2026: $22.4B expected; range $25.0B to $28.8B; 31 analysts
Show the data
| Period | Figure | Expected | Low to high | Analysts | A year earlier | Change |
|---|---|---|---|---|---|---|
| Quarter ending Dec 2026, results Jan 26, 2027 | Revenue | $6.1B | $6.0B to $6.2B | 23 | $4.4B (Dec 2025) | +37% |
| Quarter ending Mar 2027 | EPS (adjusted) | $2.62 | $2.29 to $2.88 | 22 | $1.68 (Mar 2026) | +56% |
| Quarter ending Mar 2027 | Revenue | $6.1B | $5.6B to $6.5B | 23 | $4.8B (Mar 2026) | +26% |
| Year ending Dec 2026 | EPS (adjusted) | $9.06 | $8.55 to $9.19 | 27 | — | — |
| Year ending Dec 2026 | Revenue | $22.4B | $22.0B to $22.5B | 28 | $17.7B (year to Dec 2025) | +27% |
| Year ending Dec 2027 | EPS (adjusted) | $11.58 | $9.79 to $13.50 | 27 | $9.06 (expected, year to Dec 2026) | +28% |
| Year ending Dec 2027 | Revenue | $26.3B | $25.0B to $28.8B | 31 | $22.4B (expected, year to Dec 2026) | +17% |
Targets, ratings and earnings estimates: Yahoo Finance. Rating and target changes: Yahoo Finance's list of upgrades and downgrades. The average target on each day is the average of every listed firm's latest target set in the 180 days before it, so it counts fewer analysts than the average target above, and the band is the middle half of those targets (a quarter of the firms are above it, a quarter below); a target set before a stock split is divided by the split. Expected figures: the average of the analysts' estimates (Yahoo Finance). Their EPS is adjusted, as analysts estimate it, so it is set against the adjusted EPS Yahoo reports for the same quarters, not the GAAP EPS of the growth and valuation sections; revenue against the SEC filings. No change is given against a quarter whose reported EPS was more than 50% off its own estimate (often a one-off gain or charge), nor against a year that counts one. Each estimate is pinned to its fiscal period by the report date or the period's end, and one that cannot be is left out.
Where the cash goes
Generated $7.3B in free cash flow over the year, of which $5.8B went back to shareholders (dividends plus buybacks), leaving $1.5B in the company.
Show the data
| Line | Amount |
|---|---|
| Op. cash flow | $9.9B |
| Capex | −$2.6B |
| Free cash flow | $7.3B |
| Dividends | −$5.2B |
| Buybacks | −$600M |
| Cash retained | $1.5B |
For every $100 of market cap, the company generates about $2.6 in free cash flow a year.
For every $100 of market cap, you receive about $1.8 in dividends a year.
Dividends plus buybacks over the last four quarters: for every $100 of market cap, about $2.0 went back to shareholders.
Show the data
| Quarter ended | Free cash flow | Dividends | Buybacks |
|---|---|---|---|
| Dec 2023 | $776M | $1.2B | $65M |
| Mar 2024 | −$231M | $1.2B | $3.0M |
| Jun 2024 | $507M | $1.2B | $71M |
| Sep 2024 | $416M | $1.2B | $318M |
| Dec 2024 | $806M | $1.2B | $537M |
| Mar 2025 | −$274M | $1.2B | $653M |
| Jun 2025 | $555M | $1.2B | $302M |
| Sep 2025 | $993M | $1.2B | $119M |
| Dec 2025 | $1.3B | $1.3B | $403M |
| Mar 2026 | $844M | $1.3B | $158M |
| Jun 2026 | $2.2B | $1.3B | $27M |
| Sep 2026 | $3.0B | $1.3B | $48M |
Texas Instruments had 921M diluted shares in the quarter ended Sep 2026, 0.8% more than a year earlier, and 0.1% fewer each year on average since Jun 2020. It spent $636M on buybacks over the last four quarters. Over the last four quarters its earnings per share rose 40.7% and its net income rose 41.0%: more shares took about 0 points off.
Show the data
| Quarter ended | Diluted shares |
|---|---|
| Jun 2020 | 927M |
| Sep 2020 | 929M |
| Mar 2021 | 935M |
| Jun 2021 | 937M |
| Sep 2021 | 936M |
| Mar 2022 | 934M |
| Jun 2022 | 930M |
| Sep 2022 | 923M |
| Mar 2023 | 916M |
| Jun 2023 | 916M |
| Sep 2023 | 916M |
| Mar 2024 | 917M |
| Jun 2024 | 919M |
| Sep 2024 | 920M |
| Mar 2025 | 916M |
| Jun 2025 | 912M |
| Sep 2025 | 914M |
| Mar 2026 | 914M |
| Jun 2026 | 920M |
| Sep 2026 | 921M |
Free cash flow: operating cash flow minus capital spending on property, plant and equipment, from SEC filings, for the last 4 quarters and by quarter. Shares: each quarter's diluted weighted average as filed with the SEC, since the stock's listing and its latest split.
Financial health
Current ratio 4.4, no pressure to repay short-term debt; debt-to-equity 0.9, debt is moderate.
Assets that can be turned into cash soon are 4.4x what is owed within a year. 1.5 or higher is comfortable; below 1 needs watching.
For every $1 of shareholder funds, there is $0.9 of debt. The higher the number, the more pressure when the economy weakens.
Cash and short-term investments of $4.9B against debt of $14.0B.
Latest fiscal year balance sheet. Source: Yahoo Finance.
Who holds it
In the filings of 3 members of Congress and 10 funds whose copy leaves TXN out (not traded on the exchange): Fundsmith, Nan Shan Life Insurance, Mirae Asset Global Investments, Canada Pension Plan Investment Board, Norges Bank, Baillie Gifford & and 7 more.
What did the funds Hunch tracks do?
Of the 83 funds whose 13F filings Hunch reads, 18 held TXN at the end of their latest quarter (for most, Q2 2026). Over that quarter 6 added shares, 7 cut, 4 bought new, 1 sold all and 1 held the same. The largest of them is Norges Bank, 13.22M shares worth $3.9B at Jun 30, 2026, 8.9% fewer than at Dec 31, 2025.
4 of them new holders
1 of them sold all
Show every fund
| Fund | Quarter | Shares | Value | Change in shares | Change | Filed |
|---|---|---|---|---|---|---|
| Norges Bank | Q2 2026 vs Q4 2025 | 13.22M | $3.9B | −1.29M | −8.9% | Aug 12, 2026 |
| Canada Pension Plan Investment Board | Q2 2026 | 2.39M | $713M | −299,585 | −11% | Aug 14, 2026 |
| Swiss National Bank | Q3 2026 | 2.49M | $697M | −78,600 | −3.1% | Nov 12, 2026 |
| National Pension Service | Q3 2026 | 2.14M | $599M | +19,459 | +0.9% | Nov 12, 2026 |
| Fundsmith | Q2 2026 | 1.80M | $536M | −823,942 | −31% | Aug 14, 2026 |
| Mirae Asset Global Investments | Q3 2026 | 1.84M | $514M | +361,678 | +25% | Nov 3, 2026 |
| Baillie Gifford & | Q3 2026 | 1.45M | $406M | −95,649 | −6.2% | Nov 9, 2026 |
| Renaissance Technologies | Q3 2026 | 1.09M | $305M | −313,700 | −22% | Nov 12, 2026 |
| Markel Group | Q3 2026 | 724,000 | $203M | 0 | 0.0% | Oct 30, 2026 |
| Korea Investment | Q2 2026 | 640,501 | $191M | +36,944 | +6.1% | Aug 12, 2026 |
| Nomura Holdings | Q2 2026 | 321,036 | $95.7M | +225,036 | +234% | Aug 14, 2026 |
| Tudor Investment Corp Et Al | Q2 2026 | 279,264 | $83.2M | +279,264 | New | Aug 14, 2026 |
| Nan Shan Life Insurance | Q2 2026 | 149,401 | $44.5M | +32,200 | +27% | Aug 14, 2026 |
| First Eagle Investment Management | Q3 2026 | 0 | — | −104,928 | Sold all | Nov 10, 2026 |
| Harris Associates L P | Q2 2026 | 46,260 | $13.8M | −1,250 | −2.6% | Aug 14, 2026 |
| Fisher Asset Management | Q3 2026 | 8,642 | $2.4M | +254 | +3.0% | Nov 6, 2026 |
| Soros Fund Management | Q2 2026 | 6,640 | $2.0M | +6,640 | New | Aug 14, 2026 |
| Maverick Capital | Q2 2026 | 3,924 | $1.2M | +3,924 | New | Aug 14, 2026 |
| Bridgewater Associates | Q2 2026 | 1,865 | $556K | +1,865 | New | Aug 14, 2026 |
From the 13F filings of the 83 funds Hunch tracks, not of every institution: each fund's shares of TXN at its latest quarter end against the quarter before, as filed (long positions only, options left out), the quarter before put on the latest quarter's share count across a split. A fund files 45 days after its quarter ends, so some have a newer quarter than others. Value is at the quarter end. Norges Bank filed its 13F for Q1 2026 confidentially, with no holdings made public, so its row compares Q2 2026 with Q4 2025.